Yin Biao, Zhu Yuanchang, Wu Tonghua, Shen Shuqiu, Zeng Yong, Liang Desheng
The State Key Laboratory of Medical Genetics of China, Central South University, Changsha, China.
Shenzhen Key Laboratory for Reproductive Immunology of Preimplantation, Shenzhen Zhongshan Institute for Reproduction and Genetics, Fertility Center, Shenzhen Zhongshan Urology Hospital, Shenzhen, China.
Int J Gynaecol Obstet. 2017 Mar;136(3):304-308. doi: 10.1002/ijgo.12062. Epub 2016 Dec 2.
To evaluate the pregnancy outcomes of couples containing a carrier of a reciprocal chromosome translocation (RCT) after assisted reproductive technology without preimplantation genetic diagnosis.
A retrospective study was performed using data for couples with an RCT carrier and control couples with a normal karyotype (1:4 ratio) who underwent assisted reproductive technology cycles at a Chinese fertility center in 2010-2011. The embryos were fertilized via in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Only the first pick-up cycles were used for analysis. Clinical variables were compared.
Compared with the control group (n=164), the RCT group (n=41) had a marginally lower clinical pregnancy rate (46.3% [19/41] vs 54.3% [89/164]), implantation rate (21.7% [23/106] vs 26.9% [118/438]), multiple-gestation pregnancy rate (21.1% [4/19] vs 32.6% [29/89]), and delivery rate (36.6% [15/41] vs 47.6% [78/164]), whereas the spontaneous abortion rate was slightly higher (21.1% [4/19] vs 12.4% [11/89]). However, none of these differences were significant.
The clinical outcomes for RCT carriers were acceptable after IVF/ICSI without performing preimplantation genetic diagnosis, indicating that this approach might comprise a feasible alternative fertility treatment for RCT carriers.
评估在未进行植入前基因诊断的情况下,携带相互染色体易位(RCT)的夫妇接受辅助生殖技术后的妊娠结局。
采用回顾性研究,分析2010 - 2011年在中国一家生育中心接受辅助生殖技术周期治疗的携带RCT的夫妇及核型正常的对照夫妇(比例为1:4)的数据。胚胎通过体外受精(IVF)或卵胞浆内单精子注射(ICSI)受精。仅分析首次取卵周期。比较临床变量。
与对照组(n = 164)相比,RCT组(n = 41)的临床妊娠率略低(46.3% [19/41] 对 54.3% [89/164])、着床率(21.7% [23/106] 对 26.9% [118/438])、多胎妊娠率(21.1% [4/19] 对 32.6% [29/89])和分娩率(36.6% [15/41] 对 47.6% [78/164]),而自然流产率略高(21.1% [4/19] 对 12.4% [11/89])。然而,这些差异均无统计学意义。
在未进行植入前基因诊断的情况下,RCT携带者接受IVF/ICSI后的临床结局是可接受的,这表明该方法可能是RCT携带者可行的替代生育治疗方法。